Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune cell populations interact within a complex network regulated by paracrine cytokines and direct cell-cell contact to coordinate host defense and maintain homeostasis (Nature Reviews Immunology, 2018). Paracrine signaling involves the secretion of soluble mediators like interleukins, interferons, and chemokines that influence the behavior of neighboring cells, while cell-cell contact relies on physical interactions between surface receptors and ligands, such as T-cell receptors (TCR) and major histocompatibility complex (MHC) molecules (Cell, 2020). In diseases such as cancer, this communication is often subverted to create an immunosuppressive microenvironment that allows for tumor evasion (Journal of Clinical Investigation, 2015). Conversely, in autoimmune disorders, dysregulated paracrine signaling can lead to chronic, self-destructive inflammation (Frontiers in Immunology, 2021). Therapeutic strategies targeting these interactions include monoclonal antibodies that block inhibitory checkpoints or neutralize pro-inflammatory cytokines, as well as cell-based therapies like CAR-T cells designed to engage specific cellular targets (Nature Reviews Drug Discovery, 2022). Understanding the spatial and temporal dynamics of these populations is critical for developing precision immunotherapies that can selectively modulate the immune response (Science, 2019).
Modulation of immune cell activity through the blockade or activation of paracrine signaling pathways (cytokines) and direct cell-surface receptor-ligand interactions (checkpoints) to restore or enhance immune function.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune cell populations (Paracrine and Cell-Cell Contact).